Skip to content

Efficacy and Safety Research of Autologous Adipose-derived Mesenchymal Stem Cell Gel in the Treatment of Cartilage Damage in the Knee

Efficacy and Safety Research of Autologous Adipose-derived Mesenchymal Stem Cell combine with HTO therapy in the Treatment of Cartilage Damage in the Knee

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017269
Enrollment
Unknown
Registered
2018-07-20
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Articular Cartilage Degeneration and Damage

Interventions

Experimental:HTO therapy combine with AD-MSCs + sodium hyaluronate
Control:HTO therapy combine with sodium hyaluronate

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-65 years, male and female, patient can tolerate surgery; 2) Clinical diagnosis of degenerative arthritis by Radiographic Criteria; 3) Obviously extra-articular malformation; 4) Good contralateral interventricular cartilage; 5) Course of disease = six months; 6) There was no obvious abnormality in tumor marker detection,or patient was evaluated has not at the risk of cancer; 7) Subjects who understand and sign the consent form for this study.

Exclusion criteria

Exclusion criteria: 1) Acute joint injury; 2) Patients with severe primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, and psychosis; 3) Cancer patients; 4) Women who are pregnant or breast feeding,or allergic constitution patient; 5) Positive serology for HIV-1 or HIV-2, Hepatitis B (HBsAg, Anti-HCV-Ab), Hepatitis C (Anti-HCV-Ab) and syphilis; 6) Receive other open surgery related to knee operation within 6 months; 7) Participation in another clinical trial; 8) Failing to comply with the inclusion criteria, unwilling to comply with the research approach, or incomplete data affecting the curative effect or safety judgment.

Design outcomes

Primary

MeasureTime frame
Knee cartilage volume;

Secondary

MeasureTime frame
Osteoarthritis score;Visual Analogue Scale;Quality of life;Gait analysis;

Countries

China

Contacts

Public ContactPeilai Liu

Qilu Hospital of Shandong University

gklpl@163.com+86 18560082583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026